Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 3—March 2012

Seroprevalence of Antibodies against Taenia solium Cysticerci among Refugees Resettled in United States

Seth E. O’NealComments to Author , John M. Townes, Patricia P. Wilkins, John C. Noh, Deborah Lee, Silvia Rodriguez, Hector H. Garcia, and William M. Stauffer
Author affiliations: Oregon Health & Science University, Portland, Oregon, USA (S.E. O’Neal, J.M. Townes); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P.P. Wilkins, J.C. Noh, D. Lee, W.M. Stauffer); Instituto Nacional de Ciencias Neurologicas, Lima, Peru (S. Rodriguez, H.H. Garcia); Universidad Peruana Cayetano Heredia, Lima (H.H. Garcia); University of Minnesota, Minneapolis, Minnesota, USA (W.M. Stauffer)

Main Article

Table 2

Crude and age–sex standardized seroprevalence of antibodies against Taenia solium cysts among refugees resettled in the United States

Variable Burma, n = 499 Laos, n = 502 Bhutan, n = 500 Burundi, n = 500 p value*
Age, y, median (interquartile range) 29 (22–40) 28 (20–47) 30 (22–45) 21 (18–25) <0.01†
Male, no. (%) 273 (54.7) 240 (47.8) 237 (47.4) 234 (46.8) 0.04
Seroprevalence, % (95% CI)
Crude 23.2 (19.5–27.0) 18.3 (14.9–21.7) 22.8 (19.1–26.5) 25.8 (22.0–29.6) 0.04
Age–sex standardized‡ 23.0 (19.1–26.8) 18.3 (14.9–21.7) 22.3 (18.5–26.0) 27.4 (22.8–32.0) <0.01

*Pearson χ2 unless otherwise noted.
†Kruskall-Wallis χ2.
‡Direct standardization method.

Main Article

Page created: February 16, 2012
Page updated: April 25, 2012
Page reviewed: April 25, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.